Spark Investment Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
PA
CCM
6CM
SFM
PM
Spark Investment Management's ADMA Position: Q1 2020 in Review
Spark Investment Management sold out of ADMA Biologics (ADMA) in Q1 2020, closing a stake of 22,500 shares — an estimated $90K sold.
Spark Investment Management first reported a position in ADMA in Q1 2015 and held it in 13 quarters. The position peaked at $282K in Q3 2016. 91 funds tracked by Wall St. Rank hold ADMA as of Q1 2020.
- Spark Investment Management reported no remaining ADMA Biologics position as of Q1 2020 after selling out during the quarter.
- Spark Investment Management sold 22,500 ADMA Biologics shares in Q1 2020, an estimated $90K.
- Spark Investment Management first reported a position in ADMA Biologics in Q1 2015 and held it in 13 quarters.
- Spark Investment Management's ADMA Biologics position peaked at $282K in Q3 2016.
- 91 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2020.
Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.